Collins, Stephen D.,Goldstein, Peter,Johnstone, Joshua T.
申请号：
AU2018270505
公开号：
AU2018270505A1
申请日:
2018.05.21
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present application discloses pharmaceutical compositions for modified release of huperzine. The pharmaceutical compositions and methods described herein, allow for dosing of huperzine at higher therapeutic thresholds, while avoiding rapid serum peak plasma levels, thereby avoiding the adverse nausea and vomiting associated with the immediate release pharmaceutical compositions. Methods of treating neurological disorders and/or seizure disorders with the modified release compositions is also described.
